Skip to main content
See every side of every news story
Published loading...Updated

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease

The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in on Tuesday, September 30, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal